Skip to main content

Role of edible mushroom as a potent therapeutics for the diabetes and obesity

Abstract

Diabetes and obesity are the most frequently found disease worldwide. Several factors are responsible for obesity, i.e., imbalance in energy expenditure, environmental factors, feeding habit, lifestyle, etc., which can also be responsible for type 2 diabetes mellitus. There are several synthetic drugs available to combat these diseases which have some side effects on sufferers. Therefore, people are shifting towards inexpensive, effective, widely available natural and herbal medicines. Edible mushrooms, which have been used from ancient time to cure these diseases, contain anti-oxidant, fibers, triterpenoids, alkaloid, and other phytochemicals. Comatin, β-glucan, Tremellastin, and Lentinan KS-2 are active chemicals of mushrooms which show great effect on diabetes mellitus and obesity by modulating either cellular function or biochemical pathways. Here, in this review, we have discussed the potential role of edible mushrooms and its biochemicals in control of diabetes and obesity. Using Bioinformatics, we can find the specific targets of theses biochemicals, so that these can be more effective.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2

References

  1. Agarwal S, Vaseem H, Kushwaha A, Gupta KK, Maurya S, Chaturvedi VK, Pathak RK, Singh MP (2016) Yield, biological efficiency and nutritional value of Pleurotussajor-caju cultivated on floral and agro-waste. Cell Mol Biol 62:1–5. https://doi.org/10.4172/1165-158X.1000130

    Article  Google Scholar 

  2. Aida F, Shuhaimi M, Yazid M, Maaruf A (2009) Mushroom as a potential source of prebiotics: a review. Trends Food Sci Technol 20:567–575

    CAS  Google Scholar 

  3. Alam N, Yoon KN, Lee JS, Cho HJ, Shim MJ, Lee TS (2011) Dietary effect of Pleurotuseryngii on biochemical function and histology in hypercholesterolemic rats. Saudi J Biol Sci 18:403–409

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Anai M, Funaki M, Ogihara T, Terasaki J, Inukai K, Katagiri H, Fukushima Y, Yazaki Y, Kikuchi M, Oka Y (1998) Altered expression levels and impaired steps in the pathway to phosphatidylinositol 3-kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats. Diabetes 47:13–23

    CAS  PubMed  Google Scholar 

  5. Anderson JW (1986) Dietary fiber in nutrition management of diabetes. In: Dietary fiber. Springer, pp 343–360

  6. Asrafuzzaman M, Rahman MM, Mandal M, Marjuque M, Bhowmik A, Rokeya B, Hassan Z, Faruque MO (2018) Oyster mushroom functions as an antihyperglycaemic through phosphorylation of AMPK and increased expression of GLUT4 in type 2 diabetic model rats. J Taibah Univ Med Sc 13:465–471

    Google Scholar 

  7. Badole SL, Patel NM, Thakurdesai PA, Bodhankar SL (2008) Interaction of aqueous extract of Pleurotus pulmonarius (Fr.) Quel-Champ. with glyburide in alloxan induced diabetic mice. J Evid Based Complement Altern Med 5:159–164

    Google Scholar 

  8. Benoit SC, Clegg DJ, Seeley RJ, Woods SC (2004) Insulin and leptin as adiposity signals. Recent Prog Horm Res 59:267–286

    CAS  PubMed  Google Scholar 

  9. Biswas G, Acharya K (2013) Hypoglycemic activity of ethanolic extract of Astraeus hygrometricus (Pers.) Morg. in alloxan-induced diabetic mice. Int J Pharm Pharm Sci 5:391–394

    Google Scholar 

  10. Bordonaro M, Sartorelli AC (2008) Fiber, cancer stem cells and the Wnt signalling continuum. Chin J Cancer 27:1–4

    Google Scholar 

  11. Brennan CS (2005) Dietary fibre, glycaemic response, and diabetes. Mol Nutr Food Res 49:560–570

    PubMed  Google Scholar 

  12. Canfora EE, Jocken JW, Blaak EE (2015) Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol 11:577

    CAS  PubMed  Google Scholar 

  13. Cerf ME (2013) Beta cell dysfunction and insulin resistance. Front Endocrinol (Lausanne) 4:37

    Google Scholar 

  14. Chang C-J, Lin C-S, Lu C-C, Martel J, Ko Y-F, Ojcius DM, Tseng S-F, Wu T-R, Chen Y-YM, Young JD (2015) Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat Commun 6:7489

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Chaturvedi VK, Agarwal S, Gupta KK, Ramteke PW, Singh MP (2018) Medicinal mushroom: boon for therapeutic applications. 3 Biotech 8:334

    PubMed  PubMed Central  Google Scholar 

  16. Chaturvedi VK, Singh A, Dubey SK, Hetta HF, John J, Singh MP (2019) Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma. Microb Pathol 128:184–194. https://doi.org/10.1016/j.micpath.2019.01.004

    CAS  Article  Google Scholar 

  17. Chen S-Y, Ho K-J, Hsieh Y-J, Wang L-T, Mau J-L (2012) Contents of lovastatin, γ-aminobutyric acid and ergothioneine in mushroom fruiting bodies and mycelia. LWT-Food Sci Technol 47:274–278

    CAS  Google Scholar 

  18. Chen F, Wen Q, Jiang J, Li H-L, Tan Y-F, Li Y-H, Zeng N-K (2016) Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs? J Ethnopharmacol 179:253–264

    PubMed  Google Scholar 

  19. Chorvathova V, Bobek P, Ginter E, Klvanova J (1993) Effect of the oyster fungus on glycaemia and cholesterolaemia in rats with insulin-dependent diabetes. Physiol Res 42:175

    PubMed  Google Scholar 

  20. Cornu M, Thorens B (2009) GLP-1 protects β-cells against apoptosis by enhancing the activity of an IGF-2/IGF1-receptor autocrine loop. Islets 1:280–282

    PubMed  Google Scholar 

  21. Cummings DE, Weigle DS, Frayo RS, Breen PA, Dellinger EP, Purnell JQ (2002) Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346:1623–1630

    PubMed  Google Scholar 

  22. Dangi-Garimella S (2014) The role of bioinformatics in diabetes drug development and precision medicine. Am J Manag Care 20:E1

    PubMed  Google Scholar 

  23. De Silva DD, Rapior S, Hyde KD, Bahkali AH (2012) Medicinal mushrooms in prevention and control of diabetes mellitus. Fungal Divers 56:1–29

    Google Scholar 

  24. Delzenne NM, Bindels LB (2015) Gut microbiota: Ganoderma lucidum, a new prebiotic agent to treat obesity? Nat Rev Gastroenterol Hepatol 12:553

    PubMed  Google Scholar 

  25. Delzenne NM, Neyrinck AM, Bäckhed F, Cani PD (2011) Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol 7:639

    CAS  PubMed  Google Scholar 

  26. Dietrich MO, Horvath TL (2012) Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons. Nat Rev Drug Discov 11:675

    CAS  PubMed  Google Scholar 

  27. Ding Z, Lu Y, Lu Z, Lv F, Wang Y, Bie X, Wang F, Zhang K (2010) Hypoglycaemic effect of comatin, an antidiabetic substance separated from Coprinus comatus broth, on alloxan-induced-diabetic rats. Food Chem 121:39–43

    CAS  Google Scholar 

  28. Elisashvili V, Wasser SP, Tan K-K (2002) Hypoglycemic, interferonogenous, and immunomodulatory activity of Tremellastin from the submerged culture of Tremella mesenterica Retz.: Fr. (Heterobasidiomycetes). Int J Med Mushrooms 4:1–13

    Google Scholar 

  29. Enerbäck S (2010) Brown adipose tissue in humans. Int J Obes (Lond) 34:S43

    Google Scholar 

  30. Feeney MJ, Dwyer J, Hasler-Lewis CM, Milner JA, Noakes M, Rowe S, Wach M, Beelman RB, Caldwell J, Cantorna MT (2014) Mushrooms and health summit proceedings. J Nutr 144:1128S–1136S

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Fukushima M, Nakano M, Morii Y, Ohashi T, Fujiwara Y, Sonoyama K (2000) Hepatic LDL receptor mRNA in rats is increased by dietary mushroom (Agaricusbisporus) fiber and sugar beet fiber. J Nutr 130:2151–2156

    CAS  PubMed  Google Scholar 

  32. Funahashi T, Matsuzawa Y (2007) Metabolic syndrome: clinical concept and molecular basis. Ann Med e 39:482–494

    CAS  Google Scholar 

  33. Germain N, Galusca B, Le Roux CW, Bossu C, Ghatei MA, Lang F, Bloom SR, Estour B (2007) Constitutional thinness and lean anorexia nervosa display opposite concentrations of peptide YY, glucagon-like peptide 1, ghrelin, and leptin. Am J Clin Nutr 85:967–971

    CAS  PubMed  Google Scholar 

  34. Ghaly IS, Ahmed ES, Booles HF, Farag IM, Nada SA (2011) Evaluation of antihyperglycemic action of oyster mushroom (Pleurotusostreatus) and its effect on DNA damage, diabetic patients in Denmark. Diabetologia 55:294–302

    Google Scholar 

  35. Gray A, Flatt P (1998) Insulin-releasing and insulin-like activity of Agaricus campestris (mushroom). J Endocrinol 157:259–266

    CAS  PubMed  Google Scholar 

  36. Guerciolini R (1997) Mode of action of orlistat. Int J Obes Relat Metab Disord 12–23:21

    Google Scholar 

  37. Haan H, Den Fassihi A, Soto-iniesta J, Vegara-meseguer J, Montoro S, Pérez-sánchez H (2015) Application of modern drug discovery techniques in the context of diabetes mellitus and atherosclerosis. Drug Des 4(1):1–2. https://doi.org/10.4172/2169-0138.1000e125

    CAS  Article  Google Scholar 

  38. Han C, Yuan J, Wang Y, Li L (2006) Hypoglycemic activity of fermented mushroom of Coprinus comatus rich in vanadium. J Trace Elem Med Biol 20:191–196

    CAS  PubMed  Google Scholar 

  39. Hansen M, Jensen M, Carstensen B (2012) Causes of death among diabetic patients in Denmark. Diabetologia 55:294–302

    CAS  PubMed  Google Scholar 

  40. He P, Geng L, Wang J, Xu C (2012) Characterization and bioactivities of exopolysaccharides produced by the wine cap culinary-medicinal mushroom, Strophariarugosoannulata 2#(higher basidiomycetes). Int J Med Mushrooms 14(4):365–376

    CAS  PubMed  Google Scholar 

  41. Hsieh Y-L, Yao H-T, Cheng R-S, Chiang M-T (2012) Chitosan reduces plasma adipocytokines and lipid accumulation in liver and adipose tissues and ameliorates insulin resistance in diabetic rats. J Med Food 15:453–460

    CAS  PubMed  Google Scholar 

  42. Hu S-H, Wang J-C, Lien J-L, Liaw E-T, Lee M-Y (2006) Antihyperglycemic effect of polysaccharide from fermented broth of Pleurotuscitrinopileatus. Appl Microbiol Biotechnol 70:107–113

    CAS  PubMed  Google Scholar 

  43. Huang H-Y, Korivi M, Yang H-T, Huang C-C, Chaing Y-Y, Tsai Y-C (2014) Effect of Pleurotus tuber-regium polysaccharides supplementation on the progression of diabetes complications in obese-diabetic rats. Chin J Physiol 57:198–208

    CAS  PubMed  Google Scholar 

  44. Hwang HS, Yun JW (2010) Hypoglycemic effect of polysaccharides produced by submerged mycelial culture of Laetiporussulphureus on streptozotocin-induced diabetic rats. Biotechnol Bioprocess Eng 15:173–181

    CAS  Google Scholar 

  45. Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33:245

    CAS  PubMed  Google Scholar 

  46. Jeong H-J, Yoon S-J, Pyun Y-R (2008) Polysaccharides from edible mushroom hinmogi (Tremella fuciformis) inhibit differentiation of 3T3-L1 adipocytes by reducing mRNA expression of PPARγ, C/EBPα, and leptin. Food Sci Biotechnol 17:267–273

    CAS  Google Scholar 

  47. Jong-Wonyun JW, Lee YS, Song CH (2001) A preliminary study on the hypoglycemic effect of the exo-polymers produced by five different medicinal mushrooms. J Microbiol Biotechnol 11:167–171

    Google Scholar 

  48. Kajimoto Y, Kaneto H (2004) Role of oxidative stress in pancreatic β-cell dysfunction. Ann N Y Acad Sci 1011:168–176

    CAS  PubMed  Google Scholar 

  49. Kelesidis T, Kelesidis I, Chou S, Mantzoros CS (2010) Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med 152:93–100

    PubMed  PubMed Central  Google Scholar 

  50. Kiho T, Sobue S, Ukai S (1994) Structural features and hypoglycemic activities of two polysaccharides from a hot-water extract of Agrocybecylindracea. Carbohydr Res 251:81–87

    CAS  PubMed  Google Scholar 

  51. Kiho T, Kochi M, Usui S, Hirano K, Aizawa K, Inakuma T (2001) Antidiabetic effect of an acidic polysaccharide (TAP) from Tremella aurantia and its degradation product (TAP-H). Biol Pharm Bull 24:1400–1403

    CAS  PubMed  Google Scholar 

  52. Kim SK, Hong UP, Kim JS, Kim CH, Lee KW, Choi SE, Park KH, Lee MW (2007) Antidiabetic effect of Auricularia auricula mycelia in streptozotocin-induced diabetic rats. Nat Prod Sci 13:390–393

    CAS  Google Scholar 

  53. Kim J-I, Kang M-J, Im J, Seo Y-J, Lee Y-M, Song J-H, Lee J-H, Kim M-E (2010) Effect of king oyster mushroom (Pleurotuseryngii) on insulin resistance and dyslipidemia in db/db mice. Food Sci Biotechnol 19:239–242

    CAS  Google Scholar 

  54. Koch A, Weiskirchen R, Zimmermann HW, Sanson E, Trautwein C, Tacke F (2010) Relevance of serum leptin and leptin-receptor concentrations in critically ill patients. Mediators Inflamm 2010:1–9

    Google Scholar 

  55. Kopelman PG (2000) Obesity as a medical problem. Nature 404:635

    CAS  PubMed  Google Scholar 

  56. Kwon A-H, Qiu Z, Hashimoto M, Yamamoto K, Kimura T (2009) Effects of medicinal mushroom (Sparassiscrispa) on wound healing in streptozotocin-induced diabetic rats. Am J Surg 197:503–509

    PubMed  Google Scholar 

  57. Lee I-K, Lee J-H, Yun B-S (2008) Polychlorinated compounds with PPAR-γ agonistic effect from the medicinal fungus Phellinus ribis. Bioorg Med Chem Lett 18:4566–4568

    CAS  PubMed  Google Scholar 

  58. Li S, Zhang G, Zeng Q, Huang Z, Wang Y, Dong T, Tsim K (2006) Hypoglycemic activity of polysaccharide, with antioxidation, isolated from cultured Cordyceps mycelia. Phytomedicine 13:428–433

    PubMed  Google Scholar 

  59. Li F, Zhang Y, Zhong Z (2011a) Antihyperglycemic effect of Ganoderma lucidum polysaccharides on streptozotocin-induced diabetic mice. Int J Mol Sci 12:6135–6145

    CAS  PubMed  PubMed Central  Google Scholar 

  60. Li T-H, Hou C-C, Chang CL-T, Yang W-C (2011b) Anti-hyperglycemic properties of crude extract and triterpenes from Poriacocos. J Evid Based Complement Altern Med 2011:1–8

    Google Scholar 

  61. Li N, Li L, Fang JC, Wong JH, Ng TB, Jiang Y, Wang CR, Zhang NY, Wen TY, Qu LY (2012) Isolation and identification of a novel polysaccharide–peptide complex with antioxidant, anti-proliferative and hypoglycaemic activities from the abalone mushroom. Biosci Rep 32:221–228

    PubMed  Google Scholar 

  62. Lin C-S, Chang C-J, Lu C-C, Martel J, Ojcius D, Ko Y-F, Young J, Lai H-C (2014) Impact of the gut microbiota, prebiotics, and probiotics on human health and disease. Biomed J 37:259–268

    PubMed  Google Scholar 

  63. Lindequist U, Niedermeyer THJ, Jülich W-D (2005) The pharmacological potential of mushrooms. Evid Based Complement Altern Med 2(3):285–299

    Google Scholar 

  64. Liu SH, Huang YW, Wu CT, Chiu CY, Chiang MT (2013) Low molecular weight chitosan accelerates glucagon-like peptide-1 secretion in human intestinal endocrine cells via a p38-dependent pathway. J Agric Food Chem 61:4855–4861

    CAS  PubMed  Google Scholar 

  65. Lo H-C, Tsai F-A, Wasser SP, Yang J-G, Huang B-M (2006) Effects of ingested fruiting bodies, submerged culture biomass, and acidic polysaccharide glucuronoxylomannan of Tremella mesenterica Retz.: Fr. on glycemic responses in normal and diabetic rats. Life Sci J 78:1957–1966

    CAS  Google Scholar 

  66. Ma Y, Mao D, Geng L, Wang Z, Xu C (2013) Production, fractionation, characterization of extracellular polysaccharide from a newly isolated Trametesgibbosa and its hypoglycemic activity. Carbohydr Polym 96:460–465

    CAS  PubMed  Google Scholar 

  67. MacDonald PE, El-kholy W, Riedel MJ, Salapatek AMF, Light PE, Wheeler MB (2002) The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion. Diabetes 51:434–442

    Google Scholar 

  68. Makheswari U, Sudarsanam D (2012) A review on bio informatics for diabetic mellitus. Int J Pharm Sci Res 3:389

    Google Scholar 

  69. Martel J, Ojcius DM, Chang C-J, Lin C-S, Lu C-C, Ko Y-F, Tseng S-F, Lai H-C, Young JD (2017) Anti-obesogenic and antidiabetic effects of plants and mushrooms. Nat Rev Endocrinol 13:149

    CAS  PubMed  Google Scholar 

  70. Mohammed A, Adelaiye A, Bakari A, Mabrouk M (2009) Anti-diabetic and some haematological effects of ethylacetate and n-butanol fractions of Ganoderma lucidum aqueous extract in alloxan-induced diabetic Wistar rats. Int J Med Med Sci 1:530–535

    CAS  Google Scholar 

  71. Moller DE (2001) New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414:821

    CAS  PubMed  Google Scholar 

  72. Nawrocki AR, Rajala MW, Tomas E, Pajvani UB, Saha AK, Trumbauer ME, Pang Z, Chen AS, Ruderman NB, Chen H (2006) Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor γ agonists. J Biol Chem 281:2654–2660

    CAS  PubMed  Google Scholar 

  73. Niwa A, Tajiri T, Higashino H (2011) Ipomoea batatas and Agarics blazei ameliorate diabetic disorders with therapeutic antioxidant potential in streptozotocin-induced diabetic rats. J Clin Biochem Nutr 2011:1101050064

    Google Scholar 

  74. Patel Y, Naraian R, Singh V (2012) Medicinal properties of Pleurotus species (oyster mushroom): a review. World J Fungal Plant Biol 3:1–12

    CAS  Google Scholar 

  75. Patlak M (2002) New weapons to combat an ancient disease: treating diabetes. FASEB J 16:1853e

    Google Scholar 

  76. Poddar KH, Ames M, Hsin-Jen C, Feeney MJ, Wang Y, Cheskin LJ (2013) Positive effect of mushrooms substituted for meat on body weight, body composition, and health parameters. A 1-year randomized clinical trial. Appetite 71:379–387

    PubMed  Google Scholar 

  77. Preuss HG, Echard B, Bagchi D, Perricone NV, Zhuang C (2007) Enhanced insulin-hypoglycemic activity in rats consuming a specific glycoprotein extracted from maitake mushroom. Mol Cell Biochem 306:105–113

    CAS  PubMed  Google Scholar 

  78. Ramanathan K, Karthick H, Arun N (2010) Structure based drug designing for diabetes mellitus. J Proteomics Bioinform 3:310–313. https://doi.org/10.4172/jpb.1000157

    CAS  Article  Google Scholar 

  79. Rony KA, Ajith TA, Mathew J, Janardhanan KK (2013) The medicinal cracked-cap polypore mushroom Phellinus rimosus (higher Basidiomycetes) attenuates alloxan-induced hyperglycemia and oxidative stress in rats. Int J Med Mushrooms 15:287–300

    CAS  PubMed  Google Scholar 

  80. Rui L (2013) Brain regulation of energy balance and body weight. Rev Endocr Metab Disord 14:387–407

    CAS  PubMed  Google Scholar 

  81. Sato M, Tai T, Nunoura Y, Yajima Y, Kawashima S, Tanaka K (2002) Dehydrotrametenolic acid induces preadipocyte differentiation and sensitizes animal models of noninsulin-dependent diabetes mellitus to insulin. Biol Pharm Bull 25:81–86

    PubMed  Google Scholar 

  82. Shen J, Obin MS, Zhao L (2013) The gut microbiota, obesity and insulin resistance. Mol Aspects Med 34:39–58

    CAS  PubMed  Google Scholar 

  83. Siddiqui AA, Siddiqui SA, Ahmad S, Siddiqui S, Ahsan I, Sahu K (2013) Diabetes: mechanism, pathophysiology and management: a review. Int J Drug Dev Res 5:1–23

    Google Scholar 

  84. Sobngwi E, Ndour-Mbaye M, Boateng KA, Ramaiya KL, Njenga EW, Diop SN, Mbanya J-C, Ohwovoriole AE (2012) Type 2 diabetes control and complications in specialised diabetes care centres of six sub-Saharan African countries: the Diabcare Africa study. Diabetes Res Clin Pract 95:30–36

    PubMed  Google Scholar 

  85. Sonawane HB, Ghole V, Garad S, Bapat G, Bhosle S, Apte K (2013) Hypoglycemic effect of Phansomba (Phellinus Badius Berk ex. Cooke) G. Cunn. on Alloxan-induced diabetic rats. J Nat Rem 13:29–34

    Google Scholar 

  86. Theuwissen E, Mensink RP (2008) Water-soluble dietary fibers and cardiovascular disease. Physiol Behav 94:285–292

    CAS  PubMed  Google Scholar 

  87. Topping DL (1991) Soluble fiber polysaccharides: effects on plasma cholesterol and colonic fermentation. Nutr Rev 49:195–203

    CAS  PubMed  Google Scholar 

  88. Trivedi P, Graham KL, Krishnamurthy B, Fynch S, Slattery RM, Kay TW, Thomas HE (2016) Perforin facilitates beta cell killing and regulates autoreactive CD8 + T-cell responses to antigen in mouse models of type 1 diabetes. Immunol Cell Biol 94:334–341

    CAS  PubMed  Google Scholar 

  89. Tschöp M, Smiley DL, Heiman ML (2000) Ghrelin induces adiposity in rodents. Nature 407:908

    PubMed  Google Scholar 

  90. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:1027

    Google Scholar 

  91. Vitak T, Yurkiv B, Wasser S, Nevo E, Sybirna N (2017) Effect of medicinal mushrooms on blood cells under conditions of diabetes mellitus. World J Diabet 8:187

    Google Scholar 

  92. Vrieze A, Van Nood E, Holleman F, Salojärvi J, Kootte RS, Bartelsman JF, Dallinga-Thie GM, Ackermans MT, Serlie MJ, Oozeer R (2012) Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143(913–916):e917

    Google Scholar 

  93. Waki H, Tontonoz P (2007) Endocrine functions of adipose tissue. Annu Rev Pathol Mech Dis 2:31–56

    CAS  Google Scholar 

  94. Wang C-Y, Liao JK (2012) A mouse model of diet-induced obesity and insulin resistance. In: mTOR. Springer, Totowa, pp 421–433

    Google Scholar 

  95. Wang JC, Hu SH, Wang JT, Chen KS, Chia YC (2005) Hypoglycemic effect of extract of Hericiumerinaceus. J Sci Food Agric 85:641–646

    CAS  Google Scholar 

  96. Wang L, Waltenberger B, Pferschy-Wenzig E-M, Blunder M, Liu X, Malainer C, Blazevic T, Schwaiger S, Rollinger JM, Heiss EH (2014) Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review. Biochem Pharmacol 92:73–89

    CAS  PubMed  PubMed Central  Google Scholar 

  97. Xue J, Ideraabdullah FY (2016) An assessment of molecular pathways of obesity susceptible to nutrient, toxicant and genetically induced epigenetic perturbation. J Nutr Biochem 30:1–13

    CAS  PubMed  Google Scholar 

  98. Yamac M, Kanbak G, Zeytinoglu M, Bayramoglu G, Senturk H, Uyanoglu M (2008) Hypoglycemic effect of Lentinusstrigosus (Schwein.) Fr. crude exopolysaccharide in streptozotocin-induced diabetic rats. J Med Food 11:513–517

    CAS  PubMed  Google Scholar 

  99. Yamac M, Zeytinoglu M, Kanbak G, Bayramoglu G, Senturk H (2009) Hypoglycemic effect of crude exopolysaccharides produced by Cerrena unicolor, Coprinus comatus, and Lenzitesbetulina isolates in streptozotocin-induced diabetic rats. Pharm Biol 47:168–174

    CAS  Google Scholar 

  100. Yamamoto K, Kimura T (2010) Dietary Sparassiscrispa (Hanabiratake) ameliorates plasma levels of adiponectin and glucose in type 2 diabetic mice. J Health Sci 56:541–546

    CAS  Google Scholar 

  101. Yang B-K, Kim D-H, Jeong S-C, Das S, Choi YS, Shin JS, Lee SC, Song CH (2002) Hypoglycemic effect of a Lentinusedodesexo-polymer produced from a submerged mycelial culture. Bio Sci Biotechnol Biochem 66:937–942

    CAS  Google Scholar 

  102. Yang B-K, Park J-B, Song C-H (2003) Hypolipidemic effect of an exo-biopolymer produced from a submerged mycelial culture of Hericiumerinaceus. Biosci Biotechnol Biochem 67:1292–1298

    CAS  PubMed  Google Scholar 

  103. Yang BK, Jung YS, Song CH (2007) Hypoglycemic effects of Ganoderma applanatum and Collybiaconfluensexo-polymers in streptozotocin-induced diabetic rats. Phytother Res Int J Devot Pharmacol Toxicol Eval Nat Product Deriv 21:1066–1069

    Google Scholar 

  104. Yoon KN, Lee JS, Kim HY, Lee KR, Shin PG, Cheong JC, Yoo YB, Alam N, Ha TM, Lee TS (2011) Appraisal of antihyperlipidemic activities of Lentinuslepideus in hypercholesterolemic rats. Mycobiology 39:283–289

    CAS  PubMed  PubMed Central  Google Scholar 

  105. Yuan H-D, Chung S-H (2010) Protective effects of fermented ginseng on streptozotocin-induced pancreatic β-cell damage through inhibition of NF-κB. Int J Mol Med 25:53–58

    PubMed  Google Scholar 

  106. Zhang G, Huang Y, Bian Y, Wong JH, Ng T, Wang H (2006) Hypoglycemic activity of the fungi Cordyceps militaris, Cordyceps sinensis, Tricholomamongolicum, and Omphalialapidescens in streptozotocin-induced diabetic rats. Appl Microbiol Biotechnol 72:1152–1156

    CAS  PubMed  Google Scholar 

  107. Zheng L, Zhai G, Zhang J, Wang L, Ma Z, Jia M, Jia L (2014) Antihyperlipidemic and hepatoprotective activities of mycelia zinc polysaccharide from Pholiotanameko SW-02. Int J Biol Macromol 70:523–529

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

SKD is thankful to the University Grants Commission (UGC), New Delhi, for granting research fellowship. SKD also acknowledge DBT-New Delhi facilities of Centre of Biotechnology, University of Allahabad, Prayagraj, India.

Author information

Affiliations

Authors

Contributions

SKD contributed in writing, drawing the figures and tables in this review article. VKC, DM, AB, and AT designed all the content of the article. MPS drafted and reviewed the manuscript.

Corresponding author

Correspondence to M. P. Singh.

Ethics declarations

Conflict of interest

The authors declared no conflict of interest with respect to the research, authorship, and publication of this article.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Dubey, S.K., Chaturvedi, V.K., Mishra, D. et al. Role of edible mushroom as a potent therapeutics for the diabetes and obesity. 3 Biotech 9, 450 (2019). https://doi.org/10.1007/s13205-019-1982-3

Download citation

Keywords

  • Edible mushroom
  • Bioactive compounds
  • Diabetes mellitus
  • Insulin
  • Anti-diabetic